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In a recent paper in Science, Lund et al.
[1] investigated the effect of regulatory T
cells (Tregs) on the antiviral immune
response to an acute herpes virus infection.
Previous studies on the role of Tregs in
different viral infections suggested that this
T cell population suppresses antiviral
effector T cell responses or local immune
activation at the sites of viral replication
[2,3], which might subsequently facilitate
viral immune evasion and the establish-
ment of chronic infections [4,5,6]. Thus, it
was quite surprising that ablation of Tregs
in HSV-2-infected mice resulted in an
accelerated fatal infection with increased
viral loads instead of enhanced immunity
to the virus [1]. In their fascinating paper,
the authors showed that depletion of Tregs
amplified the immune responses in drain-
ing lymph nodes at the site of infection,
but at the same time delayed the entry of
the immune cells into the HSV-2-infected
tissue. As a general concept, Lund et al.
postulated that Tregs promote immune
responses in acute infections in which the
pathogen replicates in non-lymphoid tis-
sues. However, a number of viruses that
induce severe human diseases, like HIV or
the measles virus, replicate in primary or
secondary lymphoid organs. Therefore,
the question arises whether Tregs have a
suppressive or promoting effect on antivi-
ral immune responses in infections with
viruses that are lymphotropic.
We have used the Friend retrovirus (FV)
mouse model to address this question. FV
is a lymphotropic retroviral complex that
replicates efficiently in the spleen of
infected mice and can induce a lethal
erythroleukemia [7]. It was demonstrated
in previous studies that the virus induces a
significant expansion of Tregs during
acute infection [8]. Similar to Lund et al.
[1], we used a transgenic mouse expressing
the diphtheria toxin (DT) receptor and
GFP under the control of the Foxp3
promoter [9] to selectively deplete Tregs
by DT injection during acute FV infec-
tion. DT injection into FV-infected mice
at days 0, 2, 4, 6, and 8 postinfection
depleted all GFP-expressing CD4
+ Foxp3
+
T cells in the spleen (Figure S1A), which
resulted in a slight reduction of the overall
CD4
+ T cell counts (Figure S1B). Howev-
er, a small population of cells positive for
CD4 and Foxp3 but negative for GFP
remained detectable. The DT injection
did not significantly influence the overall
numbers of CD8
+ T cells and CD19
+ B
cells in the spleen of infected mice,
indicating that the general lymphocyte
population was not affected. In addition, a
recent study clearly indicates that a DT
injection into mice expressing a DT
receptor/GFP cassette under the control
of the Foxp3 promoter leads to a specific
ablation of Tregs [10], but not to the
depletion of epithelial cells as previously
suggested by Liu et al. [11].
Since virus-specific CD8
+ T cells are the
most important immune cells that control
acute FV replication [12], we determined
the quantity and quality of these cells in
the spleen of mice experimentally ablated
of Tregs. At 10 days postinfection, signif-
icantly more CD8
+ T cells expressing
markers of effector T cells (CD43
+) were
found in the spleen of Treg-depleted mice
compared to non-depleted controls
(Figure 1A). Treg ablation also enhanced
the number of FV-specific CD8
+ T cells in
the spleen of infected mice, which were
stained with a FVgag MHC class I
tetramer [4] (Figure 1B). In addition to
the magnitude of the CD8
+ T cell
response, we analyzed the functional
properties of these T cells. After Treg
ablation, the expression of the cytotoxic
molecules granzyme A and B in splenic
CD8
+ T cells was significantly enhanced
during acute FV infection (Figure 1C and
1D), suggesting an improved cytotoxic
potential of these cells. To verify that the
enhanced granzyme production was asso-
ciated with an improved degranulation of
cytotoxic molecules by CD8
+ T cells,
expression of the degranulation marker
CD107a [13,14] was also determined.
Figure 1E shows that Treg cell depletion
significantly increased the number of
effector CD8
+ T cells expressing
CD107a. In addition, Treg ablation not
only influenced the production of cytotox-
ic molecules by antiviral CD8
+ T cells, but
also influenced their cytokine response.
After FV infection, subpopulations of the
CD8
+ T cells produced IFNc, TNFa
(Figure S2 and [15]), or low amounts of
IL-2. Treg depletion increased the per-
centage of CD8
+ T cells producing these
cytokines after FV infection (Figure S2). In
depleted mice most of the responding
CD8
+ T cells were multifunctional. Mul-
tifunctional T cells simultaneously produce
two or more cytokines and have enhanced
antiviral effector functions [16]. Most
cytokine-producing CD8
+ T cells from
DT-treated DEREG mice expressed two
or three different cytokines, whereas
in non-depleted mice the majority of
the effector CD8
+ T cells expressed only
one of the three cytokines measured
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results from Lund et al. [1], the augment-
ed virus-specific CD8
+ T cell response
decreased viral loads in the spleen more
than ten times (Figure 1F). Thus, targeted
depletion of Treg during acute FV infec-
tion resulted in superior control of viral
replication rather than an accelerated
infection as reported for HSV-2 [1]. The
results clearly show that the suppressive
activity of Tregs on antiviral immunity is
the predominant effect in viral infections
in which the primary targets of the virus
are cells of the lymphoid organs. This
suggests that the concept derived from the
study of Lund et al. [1] might mainly
apply to pathogens replicating in non-
lymphoid tissue during acute infection.
Therefore, inhibiting Treg responses ther-
apeutically in infections with lymphotropic
viruses might still be an interesting ap-
proach for antiviral treatment.
Supporting Information
Figure S1 Depletion of Tregs in FV-
infected mice expressing a DT receptor/
GFP cassette under the control of the
Foxp3 promoter by injection of DT.
DEREG mice [9] that express the DT
receptor under the control of the Foxp3
promoter were infected with FV, and
Tregs were depleted starting at the time
point of infection by five injections (days 0,
2, 4, 6, and 8 postinfection) of DT. Ten
days postinfection, depletion of Tregs and
other lymphocyte populations in the
spleen were analyzed by flow cytometry.
In all panels, FV-infected DEREG mice
that received DT (+DT, black bars) are
compared with infected DEREG mice in
which Tregs were not ablated (white bars).
(A) Shows a representative staining for
Foxp3 and GFP in gated CD4
+ T cells.
Numbers in the upper quadrants represent
Figure 1. Cytotoxic CD8
+ T cell responses and spleen viral loads in mice infected with FV and experimentally depleted of Tregs.
DEREG mice [9] were infected with FV and Tregs were depleted starting at the time point of infection by five injections (days 0, 2, 4, 6, and 8
postinfection) of DT. Ten days post infection, shortly after the peak of viral replication, CD8
+ T cell responses and viral loads in the spleen were
analyzed. In all panels, FV-infected DEREG mice receiving DT (+DT, black bars) are compared with infected DEREG mice in which Tregs were not
ablated (white bars). Statistically significant differences were calculated by the non-parametric t test and p-values are given in the figures. Six mice per
group were analyzed in two independent experiments. (A) Absolute numbers of activated CD8
+ T cells expressing the effector cell marker CD43 (over
90% of these cells were also positive for CD44 and negative for CD62L, confirming their effector phenotype [unpublished data]). (B) Absolute
numbers of activated CD8
+ T cells specific for an epitope in the FVgag gene (tetramer
+). (C and D) Absolute numbers of CD8
+ T cells expressing
granzyme A or B, respectively. (E) Absolute numbers of CD8
+ T cells expressing CD107a. (F) Spleen viral loads determined by an infectious center
assay [4].
doi:10.1371/journal.ppat.1000406.g001
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+ B cells after Treg depletion.
All experiments were performed with a
group of four mice.
Found at: doi:10.1371/journal.ppat.
1000406.s001 (1.05 MB TIF)
Figure S2 Cytokine responses of CD8
+
T cells in mice infected with FV and
experimentally depleted of Tregs. DE-
REG mice [9] were infected with FV
and Tregs were depleted starting at the
time point of infection by five injections
(days 0, 2, 4, 6, and 8 postinfection) of DT.
Ten days postinfection, cytokine responses
of CD8
+ T cell were analyzed by intracel-
lular cytokine staining for IFNc, TNFa,
and IL-2 [15]. In the figure, naı ¨ve (non-
infected), FV-infected non-depleted, and
FV-infected DEREG mice receiving DT
(+DT) were compared. Four mice per
group were analyzed. Representative re-
sults for each group are shown. Numbers
in the right section represent the percent-
ages of positive cells.
Found at: doi:10.1371/journal.ppat
1000406.s002 (1.49 MB TIF)
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